SUPPORT US
CLINICAL TRIALS
FOLLOW OUR RESEARCH
RESEARCH NEWS
2018 Highlights
Projects
Clinical Trials
samples received
Allied Health
Researchers
Even modest therapeutic advances that delay disease onset and
progression could significantly reduce the burden of the disease
on patients and the level of care required.
to gluten. For people with coeliac disease, even small amounts of gluten can damage the
lining of the small intestine (bowel). We’re undertaking research initiatives that will help
discover new ways to diagnose, treat, and manage Coeliac Disease.
in childhood. Individuals with TS make involuntary movements
and vocalisations (known as tics), which may be painful,
embarassing, and functionally impairing.
that enable us to move, speak, breath, and swallow slowly fail to work normally.
Research is sorely needed to understand and alter the progression of this condition.
Prostate Cancer Research: Targeting Improvements in Men’s Health
Prostate cancer is the third most common cancer death in Australia, with 20,000 diagnoses and close to 3,300 deaths each year. At this special Advocates Event, Urologist Dr John Yaxley, alongside Interventional Radiologist, Dr Nick Brown will shine the spotlight on two important areas of prostate cancer treatment: accurate and timely diagnosis and post-surgical care.
Wesley Medical Research Appoints New General Manager
Wesley Medical Research is pleased to announce the appointment of Dr Claudia Giurgiuman as its new General Manager to drive its next phase
Prostate Cancer Research: Targeting Improvements in Men’s Health
Prostate cancer is the third most common cancer death in Australia, with 20,000 diagnoses and close to 3,300 deaths each year. At this special Advocates Event, Urologist Dr John Yaxley, alongside Interventional Radiologist, Dr Nick Brown will shine the spotlight on two important areas of prostate cancer treatment: accurate and timely diagnosis and post-surgical care.
Wesley Medical Research Appoints New General Manager
Wesley Medical Research is pleased to announce the appointment of Dr Claudia Giurgiuman as its new General Manager to drive its next phase of growth
Run for WMR in the Bridge to Brisbane 2019
Gather your friends, family and workmates together on Sunday 25th August for a scenic 5 km or 10km’s of fun and help to raise much-needed funds for investment in research and clinical trials at Wesley Medical Research.
ImmusanT Discontinues Phase 2 Clinical Trial for Nexvax2® in Patients With Coeliac Disease
US Biotechnology company ImmusanT, Inc.
has discontinued the Phase 2 global study for its lead candidate, Nexvax2®, intended as a treatment for coeliac disease.
Thank you for visiting us at the Gluten Free Expo – 15th-16th June
Thanks for dropping by at the Gluten Free Expo Brisbane, presented by Coeliac Australia. The two-day Gluten Free Expo was an annual celebration of Australia’s best gluten-free food producers.
Saturday 15 & Sunday 16 June 2019 9am – 4pm Daily
Key Partners
Our key partners help us deliver the very best in research and help with the fight against deadly disease.
